ISAnalytics enables longitudinal and high-throughput clonal tracking studies in hematopoietic stem cell gene therapy applications
Briefings in Bioinformatics · 19.01.2023 · 24 (1)
DOI: 10.1093/bib/bbac551 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, online erschienen am 21.12.2022. Verfasst von Giulia Pais und 8 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Ospedale San Raffaele, San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Milan, Italy. Hauptthemen laut MEDLINE: Genetic Therapy, Hematopoietic Stem Cells. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Telethon Foundation, Italian Ministry of Health.
Abstract (Originalsprache)
Longitudinal clonal tracking studies based on high-throughput sequencing technologies supported safety and long-term efficacy and unraveled hematopoietic reconstitution in many gene therapy applications with unprecedented resolution. However, monitoring patients over a decade-long follow-up entails a constant increase of large data volume with the emergence of critical computational challenges, unfortunately not addressed by currently available tools. Here we present ISAnalytics, a new R package for comprehensive and high-throughput clonal tracking studies using vector integration sites as markers of cellular identity. Once identified the clones externally from ISAnalytics and imported in the package, a wide range of implemented functionalities are available to users for assessing the safety and long-term efficacy of the treatment, here described in a clinical trial use case for Hurler disease, and for supporting hematopoietic stem cell biology in vivo with longitudinal analysis of clones over time, proliferation and differentiation. ISAnalytics is conceived to be metadata-driven, enabling users to focus on biological questions and hypotheses rather than on computational aspects. ISAnalytics can be fully integrated within laboratory workflows and standard procedures. Moreover, ISAnalytics is designed with efficient and scalable data structures, benchmarked with previous methods, and grants reproducibility and full analytical control through interactive web-reports and a module with Shiny interface. The implemented functionalities are flexible for all viral vector-based clonal tracking applications as well as genetic barcoding or cancer immunotherapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- IRCCS Ospedale San Raffaele, San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Milan, Italy.
- IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
ORCID-Profile: Andrea Calabria
Förderung
- Telethon Foundation
- Italian Ministry of Health
Zitieren
APA
Pais, G., Spinozzi, G., Cesana, D., Benedicenti, F., Albertini, A., Bernardo, M. E., Gentner, B., Montini, E., & Calabria, A. (2023). ISAnalytics enables longitudinal and high-throughput clonal tracking studies in hematopoietic stem cell gene therapy applications. Briefings in Bioinformatics, 24(1). https://doi.org/10.1093/bib/bbac551
Vancouver
Pais G, Spinozzi G, Cesana D, Benedicenti F, Albertini A, Bernardo ME, et al. ISAnalytics enables longitudinal and high-throughput clonal tracking studies in hematopoietic stem cell gene therapy applications. Briefings in Bioinformatics. 2023;24(1). doi:10.1093/bib/bbac551
BibTeX
@article{Pais2023,
author = {Pais, Giulia and Spinozzi, Giulio and Cesana, Daniela and Benedicenti, Fabrizio and Albertini, Alessandra and Bernardo, Maria Ester and Gentner, Bernhard and Montini, Eugenio and Calabria, Andrea},
title = {ISAnalytics enables longitudinal and high-throughput clonal tracking studies in hematopoietic stem cell gene therapy applications},
journal = {Briefings in Bioinformatics},
year = {2023},
volume = {24},
number = {1},
doi = {10.1093/bib/bbac551}
}
EUVIMED